Literature DB >> 19879130

An estimate of overdiagnosis 15 years after the start of mammographic screening in Florence.

Donella Puliti1, Marco Zappa, Guido Miccinesi, Patrizia Falini, Emanuele Crocetti, Eugenio Paci.   

Abstract

AIM: Several studies have tried to quantify overdiagnosis of breast cancer with mammography screening, but estimates vary widely. The aim of this study is to evaluate the degree of overdiagnosis of breast cancer 15 years after the introduction of service screening in Florence (Italy).
METHODS: We selected 61,568 women aged 50-69 years at the beginning of service screening (1990) and we used the cancer registry data to follow up them for breast cancer incidence. The measure of overdiagnosis is the ratio of cumulative incidence of breast cancer in the invited group (observed) at least 5 years after the last screening to that expected in the absence of screening.
RESULTS: Under the assumption of a 1.2% annual trend in pre-screening incidence in women aged 60-69 years at the start of service screening, the ratio of observed to expected cumulative cases was 1.01 (95%CI: 0.95-1.07), but assuming no incidence trend, an unlikely scenario, the estimate of overdiagnosis rose to 1.13 (95%CI: 1.07-1.19).
CONCLUSION: Overdiagnosis of breast cancer in Florentine service screening can be estimated only for women aged 60-69 years at the start of service screening, for it is only for this group that a sufficient follow-up period is available after the last screening. Although the estimate of overdiagnosis is very sensitive to pre-screening trend estimates, our data show that 15 years after the introduction of mammographic service screening the degree of overdiagnosis was nearly zero and more than likely lower than 13% in this age group.

Entities:  

Mesh:

Year:  2009        PMID: 19879130     DOI: 10.1016/j.ejca.2009.06.014

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  19 in total

1.  Mammography, Martin Yaffe, and me: response and appreciation.

Authors:  Constantine Kaniklidis
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

Review 2.  The benefits and harms of breast cancer screening: an independent review.

Authors:  M G Marmot; D G Altman; D A Cameron; J A Dewar; S G Thompson; M Wilcox
Journal:  Br J Cancer       Date:  2013-06-06       Impact factor: 7.640

3.  Diagnosing overdiagnosis: conceptual challenges and suggested solutions.

Authors:  Bjorn Hofmann
Journal:  Eur J Epidemiol       Date:  2014-06-01       Impact factor: 8.082

4.  Advantages and Disadvantages of Mammography Screening.

Authors:  Sylvia H Heywang-Köbrunner; Astrid Hacker; Stefan Sedlacek
Journal:  Breast Care (Basel)       Date:  2011-05-27       Impact factor: 2.860

5.  Beyond the mammography debate: a moderate perspective.

Authors:  C Kaniklidis
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

6.  The overdiagnosis nightmare: a time for caution.

Authors:  Stefano Ciatto
Journal:  BMC Womens Health       Date:  2009-12-16       Impact factor: 2.809

7.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

8.  [Limits of mammography screening: current controversies and perspectives].

Authors:  K Hellerhoff
Journal:  Radiologe       Date:  2013-09       Impact factor: 0.635

9.  Balancing harms and benefits of service mammography screening programs: a cohort study.

Authors:  Donella Puliti; Guido Miccinesi; Marco Zappa; Gianfranco Manneschi; Emanuele Crocetti; Eugenio Paci
Journal:  Breast Cancer Res       Date:  2012-01-09       Impact factor: 6.466

10.  Women's views on overdiagnosis in breast cancer screening: a qualitative study.

Authors:  Jolyn Hersch; Jesse Jansen; Alexandra Barratt; Les Irwig; Nehmat Houssami; Kirsten Howard; Haryana Dhillon; Kirsten McCaffery
Journal:  BMJ       Date:  2013-01-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.